|
|
|
|
|
enzyme inhibitors (D-glucose analogue), substrate reduction therapy |
|
|
|
epothilone B analogues |
|
|
|
erythropoiesis stimulating agents (ESA) |
|
estrogen agonists/antagonists |
|
estrogen receptor antagonists |
|
|
|
estrogens, progestins |
|
extended spectrum penicillins |
|
farnesoid X receptor agonists |
|
|
|
fatty acids |
|
fenamate, nonsteroidal anti-inflammatory drugs (NSAIDs) |
|
|
|
|
|
|
|
|
|
|
|
five ht4 agonists |
|
flavanoids |
|
|
|
|
|
active factor x inhibitors |
|
|
|
adenosine receptor antagonist |
|
|
|
adrenergics, vasopressors |
